WYD: None declared. TSP: Consultant for Bayer and Pfizer (no fees). GYHL: Consultant for Bayer/Janssen, BMS/Pfizer, Medtronic, Boehringer Ingelheim, Novartis, Verseon and Daiichi-Sankyo. Speaker for Bayer, BMS/Pfizer, Medtronic, Boehringer Ingelheim, and Daiichi-Sankyo. No fees are directly received personally. The funders had no role in the submitted paper. All authors declare no conflict of interest.
M. Angelyn Bethel, Robert J. Mentz, Peter Merrill, John B. Buse, Juliana C.N. Chan, Shaun G. Goodman, Nayyar Iqbal, Neli Jakubonienė, Brian G. Katona, Yuliya Lokhnygina, Renato D. Lópes, Aldo Maggioni, Peter K. Öhman, Neil R Poulter, Ambady Ramachandran, Tsvetalina Tankova, Bernard Zinman, Adrian F. Hernandez, Rury R. Holman
Christine Teutsch, Menno V. Huisman, Professor Gregory Lip, Hans‐Christoph Diener, Sérgio Dubner, Changsheng Ma, Kenneth J. Rothman, Kristina Zint, Amelie Elsaesser, Miney Paquette, Dorothee B. Bartels, Jonathan L. Halperin
Hertzel C. Gerstein, Emil Wolsk, Brian Claggett, Rafael Díaz, Kenneth Dickstein, Sibylle Hess, Lars Køber, Aldo Maggioni, John J.V. McMurray, Jeffrey L. Probstfield, Matthew C. Riddle, Jean‐Claude Tardif, Marc A. Pfeffer
Discussion(0)
No comments yet. Be the first to comment.